Related by context. All words. (Click for frequent words.) 61 Cambridge Systematics Inc. 59 Chicago Multidisciplinary Symposium 58 CALGB 58 journal Resuscitation 57 Autism Consortium 57 Tellus Institute 56 Slone Epidemiology Center 56 Milbank Quarterly 56 Nalini Ranjit 56 firm Cerulli Associates 56 EvaluatePharma 56 BJU International 56 Idenix Pharmaceuticals 55 ROCKET AF 55 Lancet Oncology journal 55 Bruce Spiegelman 55 Kathleen Merikangas 55 Intervention Trial GAIT 55 journal Ophthalmology 54 VADT 54 Hakon Hakonarson 54 Ronald DePinho 54 T. Felson 54 Sackner Bernstein 54 Ziopharm 54 LUMINATE 54 Sherine Gabriel 54 Scientia Advisors 54 BioMedTracker 54 journal Urology 54 Replikins Ltd. 54 BioTrends 54 journal PLoS Genetics 54 Teplizumab 53 Greystone Associates 53 Heather Eliassen 53 Breast Oncology 53 Velcade bortezomib 53 Nuon Therapeutics 53 molecular entities NMEs 53 ORG IMS 53 Epilepsia 53 Dr. Denise Faustman 53 DCCT EDIC 53 ACOSOG Z# 53 PLCO 53 Dr. Kandzari 53 journal Cephalalgia 53 Clinical Psychopharmacology 53 NeuroImage 53 Pharmacoeconomic 53 Comparative effectiveness 53 Alnara Pharmaceuticals 53 NSABP 53 journal Epilepsia 53 Molecular Cancer 53 BARI 2D 53 pediatric psychopharmacology 53 BIIR 53 GSK# [002] 53 Auxilium Pharma 53 Reinherz 53 Pediatric Inflammatory Bowel Disease 53 PharMetrics 53 journal Anesthesia 53 Guillermo Torre Amione 53 Phase IIIB IV 53 Hydra Biosciences 53 Multicenter Automatic Defibrillator Implantation 52 Outcome Sciences 52 theAmerican Journal 52 Pharmaprojects 52 Dr. Gianni Belcaro 52 Dickersin 52 Prostate Cancer Prevention 52 Biopharmaceutical Industry 52 Lewis Cantley 52 Clinical Infectious Disease 52 Ambulatory Pediatrics 52 Cardiovascular Epidemiology 52 NEJM 52 clinical trials 52 PAREXEL Consulting 52 NABTT 52 journal Anticancer 52 Normative Aging Study 52 Simin Nikbin Meydani 52 Pharmacoeconomics 52 randomized controlled trials RCTs 52 Joseph Loscalzo 52 Nutritional Metabolism 52 human microdosing 52 Sina Bavari 52 Amarantus 52 Therapeutic Advances 52 ENESTnd 52 RE LY 52 EMPHASIS HF trial 52 BCIRG 52 RTOG 52 prospective nonrandomized 52 Sagient 52 journal Hepatology 52 OSUCCC 52 Gartner EXP 52 Diabetologia 52 NESARC 52 Deborah Zarin 52 ACCORD Eye 52 INTERHEART study 52 QualityMetric 52 Clinical Dermatology 52 PECARN 52 FactSet JCF Group 52 NelsonHall 52 journal Transfusion 51 prelicensure 51 Nephrology Dialysis Transplantation 51 J Immunol 51 sociologist Edward Laumann 51 Espicom 51 Ocular Hypertension Treatment 51 Clinical Antipsychotic Trials 51 RhuDex 51 Gynecologic Oncology Group 51 Richard L. Cravatts 51 InMedica 51 journal Neuropsychologia 51 journal CHEST 51 CAPRIE 51 Prostate Disease 51 HCV SPRINT 51 retrospective cohort 51 Wisconsin Sleep Cohort 51 Bexion 51 ToGA 51 Wound Care Markets 51 J Rheumatol 51 Decision Biomarkers 51 Bioequivalence 51 phase IIIb 51 Experimental Hematology 51 MEDACorp 51 HNRCA 51 Renal Cell Carcinoma RCC 51 STRIDE PD 51 Pharmacoepidemiology 51 Arch Surg 51 Stacy Tessler Lindau 51 Thorough QT 51 Cerulli Associates 51 BMC Psychiatry 51 Nasscom McKinsey 51 Cultural Cognition 51 meta regression 51 journal Nucleic Acids 51 MedPredict 51 Ariad Pharmaceuticals 51 Limerick BioPharma 51 Aflibercept 51 Clinical Therapeutics 51 Women Ischemia Syndrome 51 Deutsches Arzteblatt International 51 Immune Tolerance Network 51 IGSP 51 journal Pharmacotherapy 51 Tenthoff 51 Matthew Meyerson 51 J Clin Endocrinol Metab 51 Avalere Health LLC 51 CB Insights 51 Anticancer Agents 51 SAEC 51 Edward Giovannucci 51 Mayo Clinic oncologist 51 Progenics Pharmaceuticals 51 Canadian Multicentre Osteoporosis 51 Reproductive Toxicology 51 #th Annual Retrovirus 51 FoldRx 51 journal PNAS 50 CAMMS# 50 RE LY ® 50 Endocrine Practice 50 EMPOWER ™ 50 HORIZONS AMI 50 DAPT Study 50 NanoMarkets LC 50 MADIT CRT 50 Newton Cheh 50 firm Proleads 50 Bruce Psaty 50 journal Ambulatory Pediatrics 50 Elliott Sigal 50 Paola Sebastiani 50 Common Sense Advisory 50 Max Neeman International 50 Helmut Kaiser 50 Naurex 50 GIND 50 Wellstat 50 prospective observational studies 50 Phase IIA 50 Neuroepidemiology 50 CDER 50 journal Biomacromolecules 50 NCI CTEP 50 J Clin Oncol 50 journal Pediatric Allergy 50 pivotal bioequivalence 50 DFCI 50 Fabry Disease 50 Vaccine Immunology 50 RNA Therapeutics 50 IDC www.idc.com 50 journal Oncogene 50 metaanalysis 50 CIBMTR 50 prospective longitudinal 50 journal Nature Chemical Biology 50 Digital Mammographic Imaging 50 Dr. Robert Zivadinov 50 EBRI Issue Brief 50 Phase III placebo controlled 50 Cardiology Cardiovascular Interventions 50 tubulin inhibitor 50 multicentre prospective 50 REVIVE TA 50 Insulin Delivery Systems 50 Oncogene 50 Cancer Biomarkers 50 journal Molecular Psychiatry 50 TGaS Advisors 50 ONTARGET 50 journal Nature Reviews 50 journal Psychotherapy 50 HORIZONS AMI trial 50 Pharm Olam 50 TRITON TIMI 50 pediatric rheumatology 50 Laboratories MRL 50 Lisa Mosconi 50 Organizations ACRO 50 Amrubicin 50 Walter Jetz 50 WestEd 50 Synta Pharmaceuticals 50 Treatment Algorithms 50 ongoing Phase IIIb 50 ImQuest 50 journal Nature Immunology 50 researcher Strategy Analytics 50 Clinical Oncology JCO 50 journal Nature Chemistry 50 ADVANCE PD 50 BMC Neuroscience 50 PLoS Computational Biology 50 Streamlining Clinical Trials 50 PARTNER Trial 50 Mayo Clinic hematologist 50 rituximab Rituxan 50 Mayo Clinic endocrinologist 50 multicenter placebo controlled 50 TACI Ig 50 LSRO 50 Zinnov Management Consulting 50 Barlogie 50 DF HCC 50 Cutter Consortium 50 Arcalyst 50 CARE HF 50 Goozner 50 Investigator Initiated 50 Omnicare Clinical Research 50 Human Gene Therapy 50 neurotech 50 Cochrane Systematic Review 50 HDR Decision Economics 50 Artificial Organs 50 Meta analyzes 50 HYVET 50 Chronic Disease Outcomes 50 Immune Disease 50 Panzem 50 neurotherapeutics 50 PFO migraine 50 Kathleen Dracup 50 NASSCOM McKinsey 50 JACC Cardiovascular Interventions 49 Geriatric Society 49 TNF alpha inhibitors 49 extramural research 49 Dr. Vassilios Papadopoulos 49 Cutting Edge Information 49 EORTC 49 MDRF 49 Omacetaxine 49 CHAMPION PCI 49 Joann Petrini 49 teriflunomide 49 ixabepilone 49 Soffritti 49 placebo controlled studies 49 Cerimon 49 CASRO 49 PSMA ADC 49 Molecular Therapy 49 Analytiqa 49 journal Biological Psychiatry 49 MERLIN TIMI 49 analyst Mark Monane 49 Tolamba 49 PGx 49 Radiation Therapy Oncology 49 Carol Louik 49 clinical pharmacology studies 49 Coley Pharmaceutical Group 49 NO# [002] 49 Clinicaltrials.gov 49 PLoS Neglected Tropical Diseases 49 NATRECOR R 49 EnVivo Pharmaceuticals 49 NIAAA 49 CNS Therapeutics 49 ASGT 49 Biochemistry Microbiology 49 Guttmacher Institute nonprofit 49 journal Rheumatology 49 Biodegradable Polymers 49 bosutinib 49 multicenter trials 49 AberdeenGroup 49 elotuzumab 49 ACUITY trial 49 Pier Paolo Pandolfi 49 Kristine Yaffe MD 49 Study ADCS 49 Neurotherapeutics 49 Lennart Mucke MD 49 Carsey Institute 49 Kalorama Information 49 ACS Chemical Biology 49 Marketdata 49 Vertex Nasdaq VRTX 49 Evaluation WISE 49 QSM Associates software 49 Trandolapril 49 PROactive study 49 IOP Publishing Journal 49 Dr. Donald Redelmeier 49 MassGeneral Institute 49 Ariela Keysar 49 Science Translational Medicine 49 IntrinsiQ 49 multicenter Phase II 49 Ashish K. Jha 49 entitled Formulary Advantages 49 Toxicological Sciences 49 journal Gynecologic Oncology 49 Intervention Effectiveness CATIE 49 Monane 49 Dendreon Provenge 49 ACRIN 49 Neuroimmunology 49 Jurgen Rehm 49 Ovarian PLCO Cancer 49 anti dyslipidemic 49 Liprotamase 49 Sheldon Krimsky 49 Cancer Epidemiol Biomarkers Prev 49 Biological Therapy 49 CHAVI 49 AIDS Epidemic Update 49 Proellex TM 49 Cancer Vaccines 49 SPIRIT IV 49 International Neuropsychological Society 49 BMC Musculoskeletal Disorders 49 Katherine Flegal 49 IMPROVE HF 49 National Surgical Adjuvant 49 Scripps Gerontology Center 49 Waldenstrom Macroglobulinemia 49 IPA BDO Bellwether 49 APPRAISE 49 Conatus Pharmaceuticals 49 HayGroup 49 SWOG 49 MedMarket Diligence 49 Molecular Psychiatry 49 Framingham Offspring Study 49 Charles B. Nemeroff 49 Demark Wahnefried 49 BRIM3 49 Alice Crites 49 Anchor Therapeutics 49 Kolltan Pharmaceuticals 49 Joseph Biederman 49 WTCCC 49 Targeted Therapeutics 49 number NCT# ClinicalTrials.gov 49 EDRN 49 UCSF Headache Center 49 Institute DFCI 49 Phase Ib II 49 PLoS ONE journal 49 Lucie Bruijn 49 Sipuleucel T 49 Gantz Wiley 49 Bresalier 49 eXpert insights research 49 journal PLoS Computational Biology 49 Intensive Care Medicine 49 Zheng Cui 49 Isis Pharma 49 Dermatopathology 49 journal Lancet Neurology 49 Complications Trial 49 prospective multicentre 49 Vocalabs 49 goBalto 49 Dr. Chenchen Wang 49 chemoprevention trials 49 journal Atherosclerosis 49 Chemokine 49 ICON7 49 CAMPATH 49 Hematologic Neoplasia 49 TargeGen 48 Mien Chie Hung 48 Zycher 48 UNC Injury Prevention 48 AIR2 Trial 48 TauRx Therapeutics 48 Bipolar Disorders 48 rALLy trial 48 PloS Medicine 48 Medical Colleges AAMC 48 Clinical Outcome 48 Psycho Oncology 48 evaluating mipomersen 48 predictive toxicology 48 AP-Re/Max 48 Fuchs MD MPH 48 Kantarjian 48 publisher Packaged Facts 48 pharmacoeconomic 48 Pediatric Allergy 48 Halozyme Therapeutics 48 Adenosine Therapeutics 48 Cethromycin 48 Gerontologist 48 MD DPhil 48 entitled Treatment Algorithms 48 Anticonvulsants 48 Elio Evangelista 48 biobetter 48 George Vande Woude 48 Elizabeth Selvin 48 Lennart Mucke 48 Clinical Psychology Review 48 ePromotion 48 Tesmilifene 48 journal Arteriosclerosis Thrombosis 48 Exelixis XL# 48 Developmental Cell 48 AVADO 48 Genitourinary Cancers Symposium 48 journal Gastroenterology 48 HQK 48 Zelos Group 48 AICR WCRF 48 Idenix Pharmaceuticals Inc. 48 Phytomedics Inc. 48 multicenter phase 48 journal Diabetologia 48 Kimmie Ng 48 Inclinix 48 Elliot Sigal 48 Antibody Therapeutics 48 Biochemical Genetics 48 Infostructure Associates 48 England Centenarian Study 48 Abiraterone Acetate 48 torcetrapib atorvastatin 48 Bart De Strooper 48 atrasentan 48 Inflammatory Bowel Diseases 48 Elaine Allensworth 48 confirmatory clinical 48 Phase #b/#a 48 Anti Infectives 48 Multiple logistic regression 48 Muraglitazar 48 Celator 48 Diane Wysowski 48 Epidemiological Studies Unit 48 Screening Trial DMIST 48 Protein Therapeutics 48 Mehmet Toner 48 Bridgespan Group 48 Ann Oncol 48 A3 adenosine receptor 48 depsipeptide 48 Tokai Pharmaceuticals 48 Liberum Research 48 Hakon Hakonarson MD Ph.D. 48 RE LY trial 48 IJCP 48 journal Contraception 48 Momenta Pharmaceuticals 48 ZS Associates 48 NAACCR 48 pharmerging markets 48 EMBO Journal 48 Vectibix panitumumab 48 Preclinical Development 48 Fuji Keizai 48 Gynecological Cancer 48 BMC Infectious Diseases 48 Ellex 2RT 48 James Cerhan MD 48 Cutaneous Oncology 48 PROSTVAC TM 48 Claudia Henschke 48 BRIM2 48 CEQ# 48 ImmunoCellular Therapeutics 48 rEEG 48 clinical trial 48 Alemtuzumab 48 ASPIRE HIGHER 48 Orrin Devinsky MD 48 Cascade LifeSciences 48 FDA Critical Path 48 NAMCS 48 HealthCore 48 GenomeWeb 48 MAGE A3 ASCI 48 Applied Cognitive Psychology 48 non nucleoside HCV 48 Experimental Biology FASEB 48 Pediatric Academic Societies PAS 48 SX7P Quote Profile 48 IL# PE#QQR 48 Daniel Von Hoff 48 Arch Neurol 48 NASDAQ LIPD 48 J Clin Epidemiol 48 Philip Russom 48 Worksite Sales 48 Sequenced Treatment Alternatives 48 Zemplar Capsules 48 AUTM 48 tramiprosate Alzhemed TM 48 Pharmacogenetics 48 Combating Counterfeit Drugs 48 OPT CHF 48 IIa clinical 48 Allovectin 7 48 Ortho McNeill 48 AASLD 48 Apixaban 48 IASLC 48 Alimentary Pharmacology 48 Sidney Kimmel Cancer 48 NMEs 48 double blinded randomized 48 AHRQ 48 PHOTON Consulting 48 Getzenberg 48 MADIT II 48 research 48 Santaris 48 Nonclinical 48 ISPOR 48 Neurotology 48 meta analyzes 48 glucokinase activator 48 Intervention Effectiveness 48 Molecular Genetic 48 Ariad 48 Oxigene 48 Autoimmune Disease 48 UNC Lineberger 48 Nissen meta analysis 48 ONCONASE ranpirnase 48 multicenter clinical trials 48 Rondaxe 48 Joslin Diabetes 48 Gastrotech 48 Phase 2b monotherapy 48 ICD therapy 48 Elixir Pharmaceuticals 48 boards IRBs 48 BCG 48 Aravinda Chakravarti Ph.D. 48 J Urol 48 NCCAM 48 Emily Oken 48 Receptos 48 Chrystyna Bedrij Director 48 YONDELIS 48 Agios Pharmaceuticals 48 Carfilzomib 48 Institute DCRI 48 Cancer Immunotherapy 48 NOD mouse 48 Carotid Revascularization Endarterectomy vs. 48 SEISMIC Trial 48 ENDEAVOR clinical 48 Massimo Cristofanilli MD 48 Psychosomatic Research 48 extramural funding 48 Elena Losina 48 IOVS 48 Catherine DeAngelis 48 AcelRx 48 Pharmacogenomic 48 Zometa zoledronic acid 48 CNS Disorders 48 Circulation Heart Failure 48 Immunomedics 48 clevidipine 48 Arch Intern Med 48 Duke Translational Medicine 48 VITAL Trial 48 Acta Scandinavica 48 AEI Brookings Joint 48 Curt Furberg 48 tesmilifene 48 resected pancreatic cancer 48 Research Infosource Inc. 48 Hussain Mooraj 48 LIMRA International 48 Temsirolimus 48 Prof. Gozes 48 Tumor Microenvironment 47 SCD HeFT 47 gefitinib Iressa 47 Synovate Healthcare 47 vildagliptin 47 preclinically 47 CATIE 47 placebo controlled clinical 47 Dimes Perinatal Data 47 EMBO Molecular Medicine 47 Cardiometabolic 47 Wadih Arap 47 cerebral microbleeds 47 Formulary Forum 47 Vivus Qnexa 47 Myocet 47 mtm laboratories 47 Antimicrobial Chemotherapy 47 CommonWealth magazine 47 Professor Valerie Beral 47 Am J Pathol 47 Survey MEPS 47 Human Mutation 47 journal Catheterization 47 journal Neuropsychology 47 ASCO Breast Cancer 47 Amplimmune 47 Intarcia 47 Charles Loprinzi MD 47 Di Cera 47 Hired Brains 47 NINR 47 Vion Pharmaceuticals 47 AIM HIGH 47 PRIALT 47 perampanel 47 Phytotherapy Research 47 journal Palaios 47 Andrew Mosholder 47 UCB Cimzia 47 Eric B. Rimm 47 Dr. Pasinetti 47 Adherex Technologies 47 Navdeep Jaikaria 47 EuroIntervention 47 Phase IIb clinical trials 47 ELSI 47 Sanofi Aventis Taxotere 47 Peptimmune 47 PRECISE trial 47 HuLuc# 47 T2 Biosystems 47 Screening Trial 47 Marrow Transplant Research 47 ACCORD Lipid 47 Benign Prostatic Hyperplasia 47 Degarelix 47 TRA 2P 47 Jerry Gurwitz 47 Stenting Trial CREST 47 AVOREN 47 journal Gene Therapy 47 Human Molecular Genetics 47 transplantation immunology 47 EGS# 47 institute ITRI 47 Nuclear Medicine JNM 47 Critical Path Initiative 47 NEJM editorial 47 Xceleron 47 IDC Framingham Mass. 47 Neurosurgery Pediatrics 47 Thoracic Oncology 47 Alder Biopharmaceuticals 47 J Clin Invest 47 Trastuzumab DM1 47 Elazer Edelman 47 relapsed MM 47 Humira adalimumab 47 Biomacromolecules 47 Bridgespan 47 American Psychiatric Assn 47 Prostate AdenoCarcinoma Treatment 47 T. Perls 47 randomized trials 47 CARDIA 47 Lipid Research 47 Zafgen 47 Synergyst 47 John O. Holloszy 47 Neuropharmacology 47 PCPT 47 See CLINICAL PHARMACOLOGY 47 Investigative Dermatology 47 Empirical Legal 47 Stelara 47 NSDUH 47 Debinski 47 journal Gut 47 Hepatocellular Carcinoma HCC 47 Global Biogeochemical Cycles 47 prospectively defined 47 AVERROES 47 OvaRex ® MAb 47 JAMA 47 Veridex LLC 47 journal Neuropsychopharmacology 47 WRAIR 47 VTEUs 47 Avorn 47 CareerXroads 47 BMJ.com 47 FASgen 47 Enobia 47 journal Psychopharmacology 47 TelecomView 47 Neurodegenerative Disease 47 Mayo Clinic Alzheimer Disease 47 IPA SBRB 47 randomized multicenter trial 47 Yikyung Park 47 Ontak 47 Research Infosource 47 Phase III metastatic melanoma 47 UTSW 47 PF # [002] 47 trastuzumab DM1 T DM1 47 Phase Ib clinical 47 Cholesterol Levels SPARCL 47 denosumab oncology 47 Osiris Therapeutics 47 Giulio Maria Pasinetti 47 Diplomas Count 47 TIMI Study Group 47 Kentucky Gluck Equine 47 Vitaxin 47 GastroPlus TM 47 pexelizumab trials 47 Nat Genet 47 Dr. von Herrath 47 Trasande 47 Avalere Health consulting 47 Avonex interferon beta 1a 47 Neuropsychologia 47 ANN INTERN MED 47 Lancet Neurology journal 47 FDA Antiviral Drugs 47 Neuroinflammation 47 Developmental Therapeutics Program 47 Arul Chinnaiyan 47 Suicide Prevention Resource 47 FOLOTYN ® 47 American Geriatrics Society 47 David Turim contributed 47 Israelski 47 La Merie 47 haplotype map 47 Charlesson 47 FutureWatch 47 Schizophrenia Bulletin 47 IELEC.T Quote NEWS 47 phase IIa clinical 47 journal Animal Behaviour 47 Alnylam Nasdaq ALNY 47 Earned Doctorates 47 VLST 47 Neuradiab 47 Novel Therapies 47 KLRI 47 StemEx R 47 SWiTCH 47 Psychosomatics 47 IQWiG 47 BioNumerik 47 Beth Umland 47 Sekar Kathiresan 47 LUX Lung 47 ICAAC IDSA 47 ActivX 47 Tolerx 47 BJU Int 47 Dr. Jing Fang 47 J Exp Med 47 PloS 47 Clinical Gastroenterology 47 Marc Lipsitch 47 prognostic variables 47 #F FDG PET 47 Diabetic Medicine 47 Febuxostat 47 Dr. Ayalew Tefferi 47 Neuro Oncology 47 semistructured interviews 47 Antifungals 47 Affymax AFFY 47 Brazil IBGE statistics 47 PharmaVitae 47 Androgel R 47 NIAID Vaccine Research 47 journal Paediatrics 47 biomarker validation 47 pharmacoeconomics 47 OHR/AVR# 47 Pfizer Sutent 47 SUCCEED trial 47 Experimental Psychology General 47 Sebastian Schneeweiss 47 Tibotec BVBA 47 Bengt Winblad 47 Dr. Beilharz 47 MetaWorks 47 Enanta Pharmaceuticals 47 Sunovion 47 Taligen Therapeutics 47 Br J Cancer 47 Pharmacogenomics 47 ORACLE MS 47 Geiger Gibson RCHN 47 Erimos 47 Arteriosclerosis Thrombosis 47 RenaMed 47 Geochimica et Cosmochimica Acta 47 & Rheumatism journal 47 Paul Aisen 47 YERVOY 47 Genentech Roche Chugai 47 publisher Kalorama Information 47 HealthFocus International 47 randomized controlled clinical trials 47 Multiethnic Study 47 controlled multicenter Phase 47 cardio renal 47 Archstone Consulting 47 Bucindolol 47 Dr. Fehlings 47 Phase IIIb study 47 Onyx Pharma 47 Li Huei Tsai 47 BLP# Liposome Vaccine 47 Aab Cardiovascular Research 47 RECOTHROM R 47 ImmuneRegen BioSciences 47 AIDS Clinical Trials 47 journal Nature Photonics 47 analyst Rupert Hoogewerf 47 JAK Inhibitor 47 Biomarin 47 multicenter randomized clinical 47 Survey.com 47 HIMSS Analytics 47 firm Preqin 47 Lone Simonsen 47 Urologic Nursing 47 High Throughput Biology 47 #:#-#,# CrossRef Medline [002] 47 INC# 47 Analgesia 47 Statistical Genetics 47 GYTS 47 Enzastaurin 47 Enterprises ABLE 47 research2guidance 47 Pertuzumab 47 Advanced Magnetics 47 journal Phytotherapy Research 47 BioMarck 47 Idera Pharmaceuticals 47 ChinaBio 47 Afatinib 47 AccuStream 47 Computational Genomics 47 ENDEAVOR IV 47 Betaferon R 47 NeuroReport 47 Fuji Keizai USA 47 direct thrombin inhibitors 47 STEP BD 47 MarketingNPV 47 Thurston Arthritis 47 YONDELIS R 47 journal Psychosomatic Medicine 47 toenail onychomycosis 47 PLOS Medicine 47 WWMR 47 Telavancin 47 AnswerLab 47 journal Neurorehabilitation 47 MedPanel 47 International HapMap Consortium 47 viral kinetic 47 journal Menopause 47 Immunex Corporation 47 Locus Pharmaceuticals 47 www.thelancet.com 47 BioRexis 47 Applied Developmental Psychology 47 adalimumab Humira 47 selective androgen receptor modulators 46 Youfa Wang 46 ganetespib 46 HeFT 46 Nutrition Examination Surveys NHANES 46 Samuel Wickline 46 MMRC clinical trials 46 Early Childhood Longitudinal Study 46 Dr. Siegall 46 blinded randomized placebo controlled 46 ONCONASE R 46 MoxDuo TM IR 46 Oncomine 46 CCR5 mAb 46 Lodamin 46 Judith Hochman 46 NABE Outlook 46 NIH 46 Francine Grodstein 46 Merck Januvia 46 multicenter multinational 46 Molecular Diagnostics Laboratory 46 Yankelovich MONITOR 46 Biodesix 46 Ramon Llamas IDC 46 Phase III psoriasis 46 Neurological Disease 46 Prequin 46 Neurodegenerative Disorders 46 prospective observational cohort 46 cathepsin K inhibitor 46 GlycoMimetics 46 pharmacological therapies 46 Wilkofsky Gruen Associates 46 Patricia Hartge 46 EURIDIS 46 EnVivo Pharmaceuticals Inc. 46 Bayhill Therapeutics 46 Gil Mor 46 Tripp Umbach 46 vemurafenib 46 Zenvia Phase III 46 phase IIb trial 46 Pharmacogenetic 46 Fu Ting contributed 46 Braunwald 46 NSABP B 46 Advaxis Incorporated OTCBB ADXS 46 AEGR 46 Environ Health Perspect 46 Glucophage XR 46 Olav Zilian 46 paroxetine Paxil 46 Aggressive Reduction 46 ACORN CRO 46 Integrative Environmental 46 placebo controlled Phase 46 Maravedis 46 Pediatric Diabetes 46 Diamyd ® 46 Eli Lilly Cymbalta 46 Levetiracetam 46 Novartis Gleevec 46 journal Ethology 46 Zivadinov